Anaemia is a common condition, affecting almost a third of the global population, and is the most frequently observed impairment worldwide according to the Global Burden of Disease study. [1] This high prevalence has consequences for surgical patients. There is a growing body of literature carefully detailing the impact of preoperative anaemia on postoperative outcomes. Anaemia is independently associated with increased in-hospital mortality, allogeneic blood transfusions, length of hospital stay, intensive care admissions, surgical site infections and readmission to hospital. [2-6] Preoperative anaemia is inextricably linked to blood product utilisation in the surgical period and has become one of the three pillars of patient blood management (PBM) programmes, where the goal is to curb unnecessary blood product use and improve outcomes. [7-9] Despite increased awareness of its negative impact, preoperative anaemia remains a common finding in patients presenting for surgery, with a reported prevalence as high as 75% for certain patient groups. [2,10] Early diagnosis and management of the underlying cause of anaemia is necessary to mitigate the associated perioperative risk. Iron deficiency is the leading cause of anaemia in the general population, accounting for approximately half of all cases worldwide, [1] and up to 62% of preoperative anaemia. [11] The South African Surgical Outcomes Study (SASOS) showed that the national surgical population carries a higher perioperative risk, when matched for age and comorbidities, compared with highincome countries. [12] The overall prevalence of preoperative anaemia in the SASOS cohort was 47.8%, and anaemia was independently associated with in-hospital mortality and intensive care admissions. [13] This open-access article is distributed under Creative Commons licence CC-BY-NC 4.0.